Cargando…
Cardiac Toxicity Associated with Cancer Immunotherapy and Biological Drugs
SIMPLE SUMMARY: Immunotherapy is increasingly being used to treat solid tumors and lymphoproliferative diseases. The main classes of drugs are: HER-2-targeted therapies, CTLA-blockers, PD/PDL-1 inhibitors, CAR-T therapy. All these drugs are associated with meaningful cardiac toxicity, ranging from a...
Autores principales: | Montisci, Andrea, Vietri, Maria Teresa, Palmieri, Vittorio, Sala, Silvia, Donatelli, Francesco, Napoli, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508330/ https://www.ncbi.nlm.nih.gov/pubmed/34638281 http://dx.doi.org/10.3390/cancers13194797 |
Ejemplares similares
-
Big Data in cardiac surgery: real world and perspectives
por: Montisci, Andrea, et al.
Publicado: (2022) -
Severe Cardiac Toxicity Induced by Cancer Therapies Requiring Intensive Care Unit Admission
por: Montisci, Andrea, et al.
Publicado: (2021) -
Cardiotoxicity, Cardioprotection, and Prognosis in Survivors of Anticancer Treatment Undergoing Cardiac Surgery: Unmet Needs
por: Palmieri, Vittorio, et al.
Publicado: (2023) -
Veno-arterial Extracorporeal Membrane Oxygenation as Bridge to Heart Transplantation: The Way Forward
por: Montisci, Andrea, et al.
Publicado: (2021) -
Epigenetic Therapies for Heart Failure: Current Insights and Future Potential
por: Napoli, Claudio, et al.
Publicado: (2021)